Heme molecule functions as an endogenous agonist of astrocyte TLR2 to contribute to secondary brain damage after intracerebral hemorrhage
Open Access
- 24 June 2017
- journal article
- research article
- Published by Springer Nature in Molecular Brain
- Vol. 10 (1) , 1-10
Abstract
Toll-like receptor 2 (TLR2) was recently shown to contribute to secondary brain damage after intracerebral hemorrhage (ICH), although the molecular mechanisms of this contribution are elusive. In this study, we tested the hypothesis that hemin functions as a TLR2 endogenous agonist, causing proinflammatory astrocyte activation and secondary brain damage after ICH. Hemin administration to the mouse brain striatum induced ICH injury and neurological deficits, however, the brain injury volume and neurological deficits due to hemin injection were significantly reduced in TLR2 knock-out (KO) mice. Hemin administration induced neutrophil infiltration and upregulated neutrophil-attracting chemokine and proinflammatory cytokine expression in wild-type (WT) mice; these effects were ameliorated in TLR2 KO mice. Likewise, ICH-induced blood-brain barrier (BBB) damage was also decreased in TLR2 KO mice. This effect was most likely due to reduced matrix metalloproteinase 9 (MMP9) activity in the TLR2 KO mice compared to WT mice. In primary astrocytes, hemin directly induced MMP9 activity as well as proinflammatory cytokine and chemokine expression in a TLR2-dependent manner. Finally, hemin-induced MMP9 activity and proinflammatory gene expression were almost completely blocked by TLR2-neutralizing antibodies. Taken together, our data propose that heme released to the brain parenchyma after ICH injury activates TLR2 in astrocytes and induces inflammatory gene expression and BBB damage, which contribute to secondary brain damage after ICH.Keywords
Funding Information
- Ministry of Education, Science and Technology (NRF-2016M3C7A1905074, NRF-2016R1A2B4006288)
This publication has 31 references indexed in Scilit:
- Heme activates TLR4-mediated inflammatory injury via MyD88/TRIF signaling pathway in intracerebral hemorrhageJournal of Neuroinflammation, 2012
- High-Mobility Group Box 1 Promotes Metalloproteinase-9 Upregulation Through Toll-Like Receptor 4 After Cerebral IschemiaStroke, 2010
- Role of microglial IKKβ in kainic acid-induced hippocampal neuronal cell deathBrain, 2008
- Astrocytic Induction of Matrix Metalloproteinase-9 and Edema in Brain HemorrhageJournal of Cerebral Blood Flow & Metabolism, 2007
- Identification of genes preferentially expressed by microglia and upregulated during cuprizone‐induced inflammationGlia, 2007
- Neuroprotection by inhibition of matrix metalloproteinases in a mouse model of intracerebral haemorrhageBrain, 2005
- Hepatitis B viral HBx induces matrix metalloproteinase‐9 gene expression through activation of ERKs and PI‐3K/AKT pathways: Involvement of invasive potentialThe FASEB Journal, 2004
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Matrix Metalloproteinases and TIMPs Are Associated With Blood-Brain Barrier Opening After Reperfusion in Rat BrainStroke, 1998
- Citicoline Treatment for Experimental Intracerebral Hemorrhage in MiceStroke, 1998